Lexaria Bioscience Corp (LXX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
| 02-2022 | 11-2021 | 08-2021 | 05-2021 | 02-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 26 | 28 | 64 | 28 | 28 |
| Accounts receivable | -45 | -119 | 191 | 68 | 161 |
| Accounts payable and accrued liabilities | -73 | 89 | -73 | 27 | 63 |
| Other Working Capital | -107 | 49 | 22 | 162 | 62 |
| Other Operating Activity | -1,078 | -1,213 | -1,283 | -1,453 | -1,239 |
| Operating Cash Flow | $-1,277 | $-1,166 | $-1,079 | $-1,168 | $-924 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -42 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -34 | -16 | 0 | -71 | -3 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 273 |
| Investing Cash Flow | $-34 | $-58 | $0 | $-71 | $270 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -11 | -11 | N/A | N/A | N/A |
| Common Stock Issued | N/A | N/A | 0 | 0 | 9,471 |
| Other Financing Activity | 0 | 0 | 3,972 | 0 | -23 |
| Financing Cash Flow | $-11 | $-11 | $3,972 | $0 | $9,448 |
| Beginning Cash Position | 9,682 | 10,918 | 8,109 | 9,347 | 525 |
| End Cash Position | 8,359 | 9,682 | 10,918 | 8,109 | 9,347 |
| Net Cash Flow | $-1,323 | $-1,236 | $2,809 | $-1,238 | $8,822 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,277 | -1,166 | -1,079 | -1,168 | -924 |
| Capital Expenditure | -34 | -58 | N/A | -71 | -3 |
| Free Cash Flow | -1,312 | -1,225 | -1,079 | -1,238 | -927 |